UK Researchers Launch Unbiased AI Testing Platform for Diabetic Retinopathy Screening

Researchers unveiled a new independent platform for fair, large-scale evaluation of commercial AI algorithms detecting diabetic eye disease within the NHS.
Key Details
- 1First real-world head-to-head platform to evaluate commercial AI algorithms for NHS use in detecting diabetic eye disease.
- 2Eight CE marked AI algorithms tested on 1.2 million retinal images from one of the UK’s largest and most diverse screening programs.
- 3Algorithm performance (accuracy) ranged from 83.7% to 98.7% for clinically relevant diabetic eye disease, outperforming or matching human graders.
- 4Algorithms’ accuracy remained consistent across varied ethnic groups; first such assessment at this scale.
- 5AI analyzed images in 240ms–45s compared to up to 20 minutes for humans, vastly improving efficiency.
- 6Funded by NHS Transformation Directorate, The Health Foundation, and Wellcome Trust; study published in The Lancet Digital Health.
Why It Matters

Source
EurekAlert
Related News

AI-Powered OCT Enables Rapid 'Optical Biopsy' for Early Endometrial Cancer Detection
A team at Washington University has developed a catheter-based 3D OCT system with AI to quickly and noninvasively detect early endometrial cancers.

AI Clinical Reasoning in Diagnostics and Digital Fatigue in Healthcare
Recent JMIR features explore large language models in clinical diagnostics and digital fatigue among healthcare professionals.

KAIST, MIT, Microsoft Develop Efficient AI Image Upsampling for Robotics
KAIST, MIT, and Microsoft have created 'Upsample Anything,' a training-free AI method to restore high-resolution visual data from compressed images with up to 16x improved GPU memory efficiency.